Tci Wealth Advisors, Inc. Ligand Pharmaceuticals Inc Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	BUY	$74.52 - $117.06 $2,906 - $4,565	39 New	39 $3,000
Q1 2022 Apr 29, 2022	SELL	$94.99 - $151.56 $4,084 - $6,517	-43 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$127.69 - $165.85 $510 - $663	4 Added 10.26%	43 $7,000
Q3 2021 Oct 29, 2021	BUY	$102.33 - $144.73 $1,023 - $1,447	10 Added 34.48%	39 $5,000
Q2 2021 Aug 02, 2021	BUY	$113.03 - $155.64 $3,277 - $4,513	29 New	29 $4,000
Q1 2020 Apr 14, 2020	SELL	$63.37 - $107.88 $760 - $1,294	-12 Closed	0 $0
Q3 2019 Oct 17, 2019	SELL	$86.25 - $120.16 $517 - $720	-6 Reduced 33.33%	12 $1,000
Q2 2017 Aug 10, 2017	BUY	N/A	18	18 $2,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.